Management of Hepatitis B Infection

  • Authors: Harry L. A. Janssen, MD, PhD; Milan J. Sonneveld, MD, PhD, MSc (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 5/25/18 (What's New)

Summary

  • Interferon alfa-2b is approved in the United States for the treatment of chronic HBV infection in patients 1 year of age or older with compensated and decompensated cirrhosis (Table 3)[FDA Interferon 2b]
  • Interferon alfa-2b is rarely used for the treatment of chronic HBV infection, due to improved response rates and an easier dosing schedule with peginterferon

Action required